Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer von Mirza, Mansoor R., Chase, Dana M., Slomovitz, Brian M., dePont Christensen, René, Novák, Zoltán, Black, Destin, Gilbert, Lucy, Sharma, Sudarshan, Valabrega, Giorgio, Landrum, Lisa M., Hanker, Lars C., Stuckey, Ashley, Boere, Ingrid, Gold, Michael A., Auranen, Annika, Pothuri, Bhavana, Cibula, David, McCourt, Carolyn, Raspagliesi, Francesco, Shahin, Mark S., Gill, Sarah E., Monk, Bradley J., Buscema, Joseph, Herzog, Thomas J., Copeland, Larry J., Tian, Min, He, Zangdong, Stevens, Shadi, Zografos, Eleftherios, Coleman, Robert L., Powell, Matthew A.

Volltext

Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer von Proppe, Louisa, Alkatout, Ibrahim, Koch, Ricarda, Baum, Sascha, Kotanidis, Christos, Rody, Achim, Hanker, Lars C., Gitas, Georgios

Volltext

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) von Harter, Philipp, Hauke, Jan, Heitz, Florian, Reuss, Alexander, Kommoss, Stefan, Marmé, Frederik, Heimbach, André, Prieske, Katharina, Richters, Lisa, Burges, Alexander, Neidhardt, Guido, de Gregorio, Nikolaus, El-Balat, Ahmed, Hilpert, Felix, Meier, Werner, Kimmig, Rainer, Kast, Karin, Sehouli, Jalid, Baumann, Klaus, Jackisch, Christian, Park-Simon, Tjoung-Won, Hanker, Lars, Kröber, Sandra, Pfisterer, Jacobus, Gevensleben, Heidrun, Schnelzer, Andreas, Dietrich, Dimo, Neunhöffer, Tanja, Krockenberger, Mathias, Brucker, Sara Y, Nürnberg, Peter, Thiele, Holger, Altmüller, Janine, Lamla, Josefin, Elser, Gabriele, du Bois, Andreas, Hahnen, Eric, Schmutzler, Rita

Volltext

Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial von Pfisterer, Jacobus, Joly, Florence, Kristensen, Gunnar, Rau, Joern, Mahner, Sven, Pautier, Patricia, El-Balat, Ahmed, Kurtz, Jean-Emmanuel, Canzler, Ulrich, Sehouli, Jalid, Heubner, Martin L, Hartkopf, Andreas D, Baumann, Klaus, Hasenburg, Annette, Hanker, Lars C, Belau, Antje, Schmalfeldt, Barbara, Denschlag, Dominik, Park-Simon, Tjoung-Won, Selle, Frédéric, Jackisch, Christian, Burges, Alexander, Lück, Hans-Joachim, Emons, Günter, Meier, Werner, Gropp-Meier, Martina, Schröder, Willibald, de Gregorio, Nikolaus, Hilpert, Felix, Harter, Philipp

Volltext

Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines von Bräutigam, Karen, Kabore-Wolff, Elodie, Hussain, Ahmad Fawzi, Polack, Stephan, Rody, Achim, Hanker, Lars, Köster, Frank

Volltext

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer von Husain, Amreen, Wang, Yan, Hanker, Lars C, Ojeda, Belén, Anttila, Maarit, Breda, Enrico, Vuylsteke, Peter, Pujade-Lauraine, Eric

Volltext

Surgical outcomes of conventional laparoscopic and robotic‐assisted hysterectomy von Gitas, Georgios, Alkatout, Ibrahim, Proppe, Louisa, Werner, Nele, Rody, Achim, Hanker, Lars, Pados, George, Freytag, Damaris, Sommer, Soteris, Baum, Sascha

Volltext

Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients von El-Balat, Ahmed, Schmeil, Iryna, Karn, Thomas, Holtrich, Uwe, Mavrova-Risteska, Loreta, Rody, Achim, Youssef, Aly, Hanker, Lars C

Volltext

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial von Grünwald, Viktor, Pink, Daniel, Egerer, Gerlinde, Schalk, Enrico, Augustin, Marinela, Deinzer, Christoph K. W, Kob, Viola, Reichert, Dietmar, Kebenko, Maxim, Brandl, Stephan, Hahn, Dennis, Lindner, Lars H, Hoiczyk, Mathias, Ringsdorf, Uta, Hanker, Lars C, Hempel, Dirk, De Rivas, Beatriz, Wismann, Tobias, Ivanyi, Philipp

Volltext

Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment von Graspeuntner, Simon, Koethke, Katharina, Scholz, Celeste, Semmler, Lea, Lupatsii, Mariia, Kirchhoff, Laura, Herrmann, Jennifer, Rox, Katharina, Wittstein, Kathrin, Käding, Nadja, Hanker, Lars C, Stadler, Marc, Brönstrup, Mark, Müller, Rolf, Shima, Kensuke, Rupp, Jan

Volltext

Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature review von Cirkel, Anna, Wandinger, Klaus-Peter, Ditz, Claudia, Leppert, Jan, Hanker, Lars, Cirkel, Christoph, Neumann, Alexander, Brocke, Jan, Höftberger, Romana, Komorowski, Lars, Perner, Sven, Leypoldt, Frank, Wagner-Altendorf, Tobias, Münte, Thomas F., Royl, Georg

Volltext

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures von Karn, Thomas, Pusztai, Lajos, Holtrich, Uwe, Iwamoto, Takayuki, Shiang, Christine Y, Schmidt, Marcus, Müller, Volkmar, Solbach, Christine, Gaetje, Regine, Hanker, Lars, Ahr, Andre, Liedtke, Cornelia, Ruckhäberle, Eugen, Kaufmann, Manfred, Rody, Achim

Volltext

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer von Stürken, Christine, Möbus, Volker, Milde-Langosch, Karin, Schmatloch, Sabine, Fasching, Peter A, Rüschoff, Josef, Stickeler, Elmar, Henke, Rolf-Peter, Denkert, Carsten, Hanker, Lars, Schem, Christian, Vladimirova, Valentina, Karn, Thomas, Nekljudova, Valentina, Köhne, Claus-Henning, Marmé, Frederik, Schumacher, Udo, Loibl, Sibylle, Müller, Volkmar

Volltext

Histotype-specific analysis of acid ceramidase expression in ovarian cancer von El-Balat, Ahmed, Karn, Thomas, Holtrich, Uwe, Becker, Sven, Kommoss, Stefan, Győrffy, Balázs, Anglesio, Michael S., Huntsman, David G., Drosos, Zacharias, Rody, Achim, Gevensleben, Heidrun, Hanker, Lars C.

Volltext

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer von Stürken, Christine, Möbus, Volker, Milde-Langosch, Karin, Schmatloch, Sabine, Fasching, Peter A, Rüschoff, Josef, Stickeler, Elmar, Henke, Rolf-Peter, Denkert, Carsten, Hanker, Lars, Schem, Christian, Vladimirova, Valentina, Karn, Thomas, Nekljudova, Valentina, Köhne, Claus-Henning, Marmé, Frederik, Schumacher, Udo, Loibl, Sibylle, Müller, Volkmar

Volltext

Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancer von Hanker, Lars C, Karn, Thomas, Holtrich, Uwe, Graeser, Monika, Becker, Sven, Reinhard, Joscha, Ruckhäberle, Eugen, Gevensleben, Heidrun, Rody, Achim

Volltext

Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes von Hanker, Lars C., Rody, Achim, Holtrich, Uwe, Pusztai, Lajos, Ruckhaeberle, Eugen, Liedtke, Cornelia, Ahr, Andre, Heinrich, Tomas M., Sänger, Nicole, Becker, Sven, Karn, Thomas

Volltext

What is the evidence for lymphadenectomy in presumed early ovarian cancer? von Schmalfeldt, Barbara, Brambs, Christine, Burges, Alexander, El-Balat, Ahmed, Emons, Günter, Fink, Daniel, Fotopoulou, Christina, Gropp-Meier, Martina, Hanker, Lars-Christian, Harter, Philipp, Hasenburg, Annette, Hauptmann, Steffen, Hilpert, Felix, Kimmig, Rainer, Kommoss, Stefan, Kurzeder, Christian, Mahner, Sven, Marmé, Frederik, Mayr, Doris, Meier, Werner, Meinhold-Heerlein, Ivo, Mustea, Alexander, Ortmann, Olaf, Oskay-Özcelik, Gülten, Pfisterer, Jacobus, Pölcher, Martin, Runnebaum, Ingo B., Schröder, Willibald, Tanner, Berno, Wagner, Uwe, Wimberger, Pauline, Sehouli, Jalid

Volltext

Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors von Emons, Günter, Kaufmann, Manfred, Gorchev, Grigor, Tsekova, Valentina, Gründker, Carsten, Günthert, Andreas R, Hanker, Lars C, Velikova, Maya, Sindermann, Herbert, Engel, Jürgen, Schally, Andrew V

Volltext

Lymphknotenstaging bei Genitalkarzinomen – wohin geht die Reise? von Proppe, Louisa, Rody, Achim, Hanker, Lars C

Volltext